Helen M. Colhoun

1 ta ish

University of Edinburgh

1. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

   Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais +97

   MaqolaOAOchiq kirish20192 iqtibos

   ABIABI:AkademIndex/2026.other.057761